Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hebert

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Clinical Pharmacology and Therapeutics|November 1, 1995
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporineC Y Wu, L Z Benet, M F Hebert, et al.
Biochemical Pharmacology|March 18, 2008
Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancyLeslie J Dickmann, Suzanne Tay, Tauri D Senn, et al.
Biochemical Pharmacology|September 29, 2004
In vitro metabolism of cyclosporine A by human kidney CYP3A5Yang Dai, Kazunori Iwanaga, Yvonne S Lin, et al.
Cancer Chemotherapy and Pharmacology|January 13, 2006
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecanAnshul Gupta, Yang Dai, R Robert Vethanayagam, et al.
Journal of Human Lactation : Official Journal of International Lactation Consultant Association|March 16, 2013
Duration of cisplatin excretion in breast milkKaren E Hays, Rachel J Ryu, Elizabeth M Swisher, et al.
Metabolites|September 27, 2023
Effects of Pregnancy on Plasma Sphingolipids Using a Metabolomic and Quantitative Analysis ApproachLuke F Enthoven, Yuanyuan Shi, Emily Fay, et al.
Clinical Pharmacology and Therapeutics|July 1, 1997
Tacrolimus oral bioavailability doubles with coadministration of ketoconazoleL C Floren, I Bekersky, L Z Benet, et al.
British Journal of Clinical Pharmacology|October 21, 2023
Effect of isotretinoin on CYP2D6 and CYP3A activity in patients with severe acneYuqian Zhao, Jay C Vary, Aprajita S Yadav, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2015
Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored WorkshopDanielle M Carrick, Anil K Chaturvedi, Meredith S Shiels, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine PharmacokineticsS K Quinney, A N Mohamed, M F Hebert, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|November 1, 1995
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporineC Y Wu, L Z Benet, M F Hebert, et al.
Biochemical Pharmacology|March 18, 2008
Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancyLeslie J Dickmann, Suzanne Tay, Tauri D Senn, et al.
Biochemical Pharmacology|September 29, 2004
In vitro metabolism of cyclosporine A by human kidney CYP3A5Yang Dai, Kazunori Iwanaga, Yvonne S Lin, et al.
Cancer Chemotherapy and Pharmacology|January 13, 2006
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecanAnshul Gupta, Yang Dai, R Robert Vethanayagam, et al.
Journal of Human Lactation : Official Journal of International Lactation Consultant Association|March 16, 2013
Duration of cisplatin excretion in breast milkKaren E Hays, Rachel J Ryu, Elizabeth M Swisher, et al.
Metabolites|September 27, 2023
Effects of Pregnancy on Plasma Sphingolipids Using a Metabolomic and Quantitative Analysis ApproachLuke F Enthoven, Yuanyuan Shi, Emily Fay, et al.
Clinical Pharmacology and Therapeutics|July 1, 1997
Tacrolimus oral bioavailability doubles with coadministration of ketoconazoleL C Floren, I Bekersky, L Z Benet, et al.
British Journal of Clinical Pharmacology|October 21, 2023
Effect of isotretinoin on CYP2D6 and CYP3A activity in patients with severe acneYuqian Zhao, Jay C Vary, Aprajita S Yadav, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2015
Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored WorkshopDanielle M Carrick, Anil K Chaturvedi, Meredith S Shiels, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine PharmacokineticsS K Quinney, A N Mohamed, M F Hebert, et al.
Pageof 15